<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="6800 and cobasÂ® 8800 (approved in testing patient samples by" exact="the US" post="FDA), which can process up to 384 results and"/>
 <result pre="screening capacity to help restrain the sudden growing epidemic in" exact="the USA." post="RT-PCR is widely applicable to 2019-nCoV detection in the"/>
 <result pre="bold, novel approach, a team of infectious disease experts in" exact="Singapore" post="utilized an ELISA against 2019-nCoV to ascertain that suspected"/>
 <result pre="efficiency and safety against 2019-nCoV in clinical trials conducted in" exact="China" post="[139]. Currently, chloroquine or hydroxychloroquine has been administered to"/>
 <result pre="2019-nCoV patients on an uncontrolled basis in various countries, including" exact="China" post="and the USA [42]. However, it must be noted"/>
 <result pre="on an uncontrolled basis in various countries, including China and" exact="the USA" post="[42]. However, it must be noted that chloroquine and"/>
 <result pre="and production of viral particles [158]. A clinical study from" exact="Hong Kong" post="has shown that the combination of lopinavir-ritonavir and ribavirin"/>
 <result pre="[229]. To date, the National Health Commission (NHC) of the" exact="People's Republic of China" post="has published seven editions of the guidelines for diagnosis"/>
 <result pre="To date, the National Health Commission (NHC) of the People's" exact="Republic of" post="China has published seven editions of the guidelines for"/>
 <result pre="the National Health Commission (NHC) of the People's Republic of" exact="China" post="has published seven editions of the guidelines for diagnosis"/>
 <result pre="recommended for treatment of COVID-19 by the NHC of the" exact="People's Republic of China," post="because it gave a cure rate of over 90%"/>
 <result pre="for treatment of COVID-19 by the NHC of the People's" exact="Republic of" post="China, because it gave a cure rate of over"/>
 <result pre="COVID-19 patients, because it suppresses severe sepsis, according to the" exact="China" post="Food and Drug Administration. It also promoted significant improvement"/>
 <result pre="The currently adopted procedure in identifying potential COVID-19 cases in" exact="China" post="is summarized in Figure 10. On a community scale"/>
 <result pre="traffic are essential to limiting disease transmission. By establishing lockdowns," exact="China" post="has been able to bring the crisis under control."/>
 <result pre="spread of 2019-nCoV. Acknowledgments This work was supported by the" exact="Singapore" post="Ministry of Education (MOE2017-T2-2-110); Agency for Science, Technology and"/>
 <result pre="programme (Award No. NRF-NRFI05-2019-0003); and National Natural Science Foundation of" exact="China" post="(21771135). Conflicts of Interest The authors declare no conflicts"/>
 <result pre="2020China CDC Weekly20202113122 25collab: National Health Committee of the People's" exact="Republic of" post="ChinaDiagnosis and treatment guidelines for COVID-19April 2020, http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml 26StrobelE."/>
 <result pre="with chain-terminating inhibitorsProceedings of the National Academy of Sciences of" exact="the United States" post="of America197774125463546710.1073/pnas.74.12.5463271968 28WangM.FuA.HuB.et al.Nanopore target sequencing for accurate and"/>
 <result pre="chain-terminating inhibitorsProceedings of the National Academy of Sciences of the" exact="United States" post="of America197774125463546710.1073/pnas.74.12.5463271968 28WangM.FuA.HuB.et al.Nanopore target sequencing for accurate and"/>
 <result pre="64VogelsteinB.KinzlerK. W.Digital PCRProceedings of the National Academy of Sciences of" exact="the United States" post="of America199996169236924110.1073/pnas.96.16.923610430926 65KimD.WeiQ.KongJ. E.OzcanA.Di CarloD.Research highlights: digital assays on"/>
 <result pre="W.Digital PCRProceedings of the National Academy of Sciences of the" exact="United States" post="of America199996169236924110.1073/pnas.96.16.923610430926 65KimD.WeiQ.KongJ. E.OzcanA.Di CarloD.Research highlights: digital assays on"/>
 <result pre="antiviral drug ArbidolProceedings of the National Academy of Sciences of" exact="the United States" post="of America2017114220621410.1073/pnas.161702011428003465 123ShenZ.LouK.WangW.New small-molecule drug design strategies for fighting"/>
 <result pre="drug ArbidolProceedings of the National Academy of Sciences of the" exact="United States" post="of America2017114220621410.1073/pnas.161702011428003465 123ShenZ.LouK.WangW.New small-molecule drug design strategies for fighting"/>
 <result pre="inhibition by darunavirProceedings of the National Academy of Sciences of" exact="the United States" post="of America201411133122341223910.1073/pnas.140002711125092296 164LinS.ShenR.HeJ.LiX.GuoX.Molecular modeling evaluation of the binding effect"/>
 <result pre="by darunavirProceedings of the National Academy of Sciences of the" exact="United States" post="of America201411133122341223910.1073/pnas.140002711125092296 164LinS.ShenR.HeJ.LiX.GuoX.Molecular modeling evaluation of the binding effect"/>
 <result pre="by using ribavirinProceedings of the National Academy of Sciences of" exact="the United States" post="of America200198126895690010.1073/pnas.11108559811371613 173TeH. S.RandallG.JensenD. M.Mechanism of action of ribavirin"/>
 <result pre="using ribavirinProceedings of the National Academy of Sciences of the" exact="United States" post="of America200198126895690010.1073/pnas.11108559811371613 173TeH. S.RandallG.JensenD. M.Mechanism of action of ribavirin"/>
 <result pre="a broad spectrum inhibitor of viral RNA polymeraseProceedings of the" exact="Japan" post="Academy, Series B201793744946310.2183/pjab.93.02728769016 183CaiQ.YangM.LiuD.et al.Experimental treatment with favipiravir for"/>
 <result pre="Traditional and Herbal Drugs202051878882 231collab: Publicity Department of the People's" exact="Republic of" post="ChinaPress conference of the joint prevention and control mechanism"/>
 <result pre="COVID-19 test kits used to screen swab samples collected at" exact="Singapore" post="checkpoints2020https://www.channelnewsasia.com/news/singapore/covid19-new-test-kits-swab-three-hours-12505658 250collab: Beihang UniversityThe development of Beihang University on"/>
 <result pre="of the 2019-nCoV grown in cells at the University of" exact="Hong Kong" post="[97]. Figure 8 Proposed schematic of 2019-nCoV replication and"/>
 <result pre="N/A Compared with favipiravir (see favipiravir) Currently being evaluated in" exact="China" post="Chloroquine, hydroxychloroquine Entry receptor Antiviral drug on malaria; not"/>
 <result pre="on primate cells [135, 138] Ongoing Currently being evaluated in" exact="China" post="and the United States Camostat mesylate Host protease Antiviral"/>
 <result pre="cells [135, 138] Ongoing Currently being evaluated in China and" exact="the United States" post="Camostat mesylate Host protease Antiviral drug on pancreatic diseases;"/>
 <result pre="[135, 138] Ongoing Currently being evaluated in China and the" exact="United States" post="Camostat mesylate Host protease Antiviral drug on pancreatic diseases;"/>
 <result pre="ribavirin for SARS and MERS N/A 199 hospitalized patients, Wuhan," exact="China" post="(99 lopinavir+ritonavir+100 standard care) [161] Currently being evaluated in"/>
 <result pre="China (99 lopinavir+ritonavir+100 standard care) [161] Currently being evaluated in" exact="China" post="and the United States. However, found to be ineffective"/>
 <result pre="lopinavir+ritonavir+100 standard care) [161] Currently being evaluated in China and" exact="the United States." post="However, found to be ineffective based on preliminary findings"/>
 <result pre="standard care) [161] Currently being evaluated in China and the" exact="United States." post="However, found to be ineffective based on preliminary findings"/>
 <result pre="SARS and MERS N/A Not known Currently being evaluated in" exact="China" post="Favipiravir Genome replication Antiviral drug on influenza; not yet"/>
 <result pre="yet tested for coronaviruses N/A 240 patients in Hubei province," exact="China" post="(120 favipiravir+120 arbidol) (preprint) [184] Higher recovery rate compared"/>
 <result pre="boost Janssen Pharmaceutical Companies N/A Protein subunit/S protein EpiVax/Univ. of" exact="Georgia" post="GV-MVA-VLP/vaccine DNA/nonreplicating viral vector GeoVax/BravoVax Protein subunit/S protein (baculovirus"/>
 <result pre="Live attenuated virusâˆ— Deoptimized live attenuated vaccines Codagenix/Serum Institute of" exact="India" post="N/A mRNA vaccine/lipid nanoparticle/S and S-RBD antigen Fudan University/Shanghai"/>
 <result pre="Sinovac BNT162âˆ— mRNA vaccine BioNTech/Fosun Pharma/Pfizer N/A Unknown University of" exact="Hong Kong" post="N/A Self-amplifying RNA vaccine Imperial College London N/A Unknown/IPA's"/>
</results>
